10.1016/j.yend.2013.10.001
article
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper investigated the potential of adipose-derived mesenchymal stem cells (ADSCs) to differentiate into insulin-producing cells for diabetes treatment.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism 2013
- Effects of Combined Oral Contraceptive Ethinylestradiol (30 μg) and Dienogest (2 mg) on Carbohydrate Metabolism During 1 Year of Conventional or Extended-Cycle Use 2010
- The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight–obese younger postmenopausal women 2008
References (5)
- Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism via openalex
- Effects of Combined Oral Contraceptive Ethinylestradiol (30 μg) and Dienogest (2 mg) on Carbohydrate Metabolism During 1 Year of Conventional or Extended-Cycle Use via openalex
- The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight–obese younger postmenopausal women via openalex
- doi:10.1007/s11154-011-9182-4 via openalex
- doi:10.1002/14651858.cd006133.pub4 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T03:36:32.530589+00:00
License: CC0
· commercial use OK